Literature DB >> 25199012

Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.

A Chaiprasert1, S Srimuang2, N Tingtoy1, N Makhao2, P Sirirudeeporn2, N Tomnongdee2, O Theankeaw2, S Charoensook2, M Leechawengwongs2, T Prammananan2.   

Abstract

The increasing incidence of multidrug-resistant tuberculosis (MDR-TB) and the emergence of extensively drug-resistant tuberculosis (XDR-TB) globally hamper the successful treatment and effective control of TB. Information on second-line drug susceptibility, which is of utmost importance for patient care, is still limited. This study demonstrates the susceptibilities of 1447 strains of MDR-TB, including 58 XDR-TB strains, isolated from Siriraj Hospital, Bangkok, Thailand, to aminoglycosides, fluoroquinolones, ethionamide (ETH), para-aminosalicylic acid (PAS) and linezolid. Results revealed that 93-94% of the MDR-TB strains were susceptible to aminoglycosides, 85-98% to fluoroquinolones, 78% to ETH, 85% to PAS and 99% to linezolid.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199012     DOI: 10.5588/ijtld.13.0197

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand.

Authors:  Manoon Leechawengwongs; Therdsak Prammananan; Sarinya Jaitrong; Pamaree Billamas; Nampueng Makhao; Nongnard Thamnongdee; Arirat Thanormchat; Arisa Phurattanakornkul; Somcharn Rattanarangsee; Chate Ratanajaraya; Areeya Disratthakit; Angkana Chaiprasert
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.

Authors:  Areeya Disratthakit; Therdsak Prammananan; Chanwit Tribuddharat; Iyarit Thaipisuttikul; Norio Doi; Manoon Leechawengwongs; Angkana Chaiprasert
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999-2013.

Authors:  Beibei Wu; Le Zhang; Zhengwei Liu; Haibo He; Aizhen Pan; Fei Wang; Mingwu Zhang; Bin Chen; Zuhong Lu; Songhua Chen; Xiaomeng Wang
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

4.  Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis.

Authors:  Taher Azimi; Saeed Khoshnood; Arezoo Asadi; Mohsen Heidary; Hassan Mahmoudi; Vahab Hassan Kaviar; Masoume Hallajzadeh; Mohammad Javad Nasiri
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.